Basit öğe kaydını göster

dc.contributor.authorKaraali-Savrun, F
dc.contributor.authorSaip, S
dc.contributor.authorAltintas, A
dc.contributor.authorSiva, A
dc.date.accessioned2021-03-05T09:29:17Z
dc.date.available2021-03-05T09:29:17Z
dc.date.issued2001
dc.identifier.citationKaraali-Savrun F., Altintas A., Saip S., Siva A., "Hepatitis B vaccine related-myelitis?", EUROPEAN JOURNAL OF NEUROLOGY, cilt.8, ss.711-715, 2001
dc.identifier.issn1351-5101
dc.identifier.othervv_1032021
dc.identifier.otherav_9e1137d3-f32b-4cda-abca-348b5fdba28f
dc.identifier.urihttp://hdl.handle.net/20.500.12627/106167
dc.identifier.urihttps://doi.org/10.1046/j.1468-1331.2001.00290.x
dc.description.abstractWe present four incidental cases that developed partial myelitis following the administration of hepatitis B vaccine in 1998. The first two cases, a 33-year-old man and a 42-year-old woman developed progressive sensory symptoms without motor involvement within 4 weeks following the vaccination. Their magnetic resonance imaging (MRI) disclosed similar lesions consistent with myelitis at their cervical spinal cord. A comparable inflammatory lesion was seen at the T9-T10 levels of the spinal cord in the third case, who was a 40-year-old woman presenting with numbness in her legs and urinary retention following the vaccination. The fourth case who was a 42-year-old woman, presented with sensory symptoms in her left extremities, which developed 3 months after the vaccination. Her MRI showed a hyperintense lesion at C6. She also had two tiny lesions in her cranial MRI. In all cases, there was no history of preceding infections and no clinical evidence suggestive of any other disorders that may cause myelopathy. All patients recovered completely within 3 months with the exception of the third patient who developed new neurological symptoms after 12 months. Similar clinical and imaging presentation of myelitis following hepatitis B vaccination within a 1 year period with no other demonstrable clinical and laboratory evidence for any other disorder raise the probability of a causal link between these two events.
dc.language.isoeng
dc.subjectKLİNİK NEUROLOJİ
dc.subjectNEUROSCIENCES
dc.subjectSinirbilim ve Davranış
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNöroloji
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleHepatitis B vaccine related-myelitis?
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF NEUROLOGY
dc.contributor.department, ,
dc.identifier.volume8
dc.identifier.issue6
dc.identifier.startpage711
dc.identifier.endpage715
dc.contributor.firstauthorID163465


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster